Insider · CIK 0001715258
Juliet Thompson
Files at INDV (Indivior Pharmaceuticals, Inc.). First filing -, latest -.
Juliet Thompson files SEC Form 4 as director at INDV (Indivior Pharmaceuticals, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Juliet Thompson has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 26, 2026 | INDV Indivior Pharmaceuticals, Inc. | AGrant or award Common Stock | +3,722 | $0.00 | $0 | 7,572 | Jan 28, 2026 |
Questions about Juliet Thompson
Answered from the filings on this page, as of the latest one.
Is Juliet Thompson buying or selling?
Juliet Thompson has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Juliet Thompson's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Juliet Thompson has 0.
Where does Juliet Thompson file Form 4?
Juliet Thompson has filed Form 4 at INDV (Indivior Pharmaceuticals, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.